In this issue:
- 2023 ESC guidelines for managing endocarditis
- 2023 ESC guidelines for ACS
- Guideline for diagnosing and managing AF
- Expert consensus statement on cardiac catheterisation for CHD
- Urgent ECMO after cardiogenic shock admission could lower mortality
- Increasing lipids with risk of worsening cardiac damage in adolescents
- New warnings of romosozumab (Evenity) CV risks
- ESC guidelines and documents planned for 2024
- Real-world incidence of severe QT prolongation in patients taking antipsychotic drugs
- Chronic hypertension and the risk of readmission for postpartum CV complications
- Utility of smartwatches for identifying arrhythmias in children
- COVID-19 resources